Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
This Bitcoin-focused microcap is building a treasury strategy centered on accumulating BTC (click to learn more) Laser Photonics Reports Full Year Total Net Sales Increase of 144% in Q4 2025 Financial Results (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Price History  |  Ratios  |  Insiders

Stock Quote Today & Recent News Stella Diagnostics Inc (ID) SLDX

Healthcare Biotechnology Diagnostics & Research
Stella Diagnostics, Inc., a research diagnostics company, engages in developing molecular diagnostics tools and new drug targets for esophageal diseases. It uses targeted mass spectrometry to determine the level of disease progression in tissue of the lower esophagus. The company’s technology informs gastroenterologists, surgical oncologists, and pathologists, which patients are high risk for... see more

Current News ()

Stella Diagnostics and Mayo Clinic to Present Data on the Utility of the STLA101 Test for Esophageal Cancer Staging at the 2022 AGA Digestive Disease Week Conference

GlobeNewswire May 11, 2022

Stella Diagnostics Announces Leadership Changes: Dr. Joe Abdo Assumes a New Role as Chief Scientific Officer, and Director David Seaburg is Appointed Chief Executive Officer

GlobeNewswire April 22, 2022

Stella Diagnostics Announces Data Presentation at the American Association for Cancer Research (AACR) Annual Meeting

GlobeNewswire April 6, 2022

Stella Diagnostics to Present at "Next Big Thing" Session at Society of American Gastroenterologists and Endoscopic Surgeons Annual Meeting

GlobeNewswire March 2, 2022

Stella Diagnostics Named 'Best Clinical Proteomics Solution' of 2021 by Biotech Breakthrough Awards

GlobeNewswire February 16, 2022

Stella Diagnostics CEO Discusses Competitive Advantage in Early Cancer Detection During Audio Interview with SmallCapVoice.com

GlobeNewswire February 15, 2022

Stella Diagnostics and Collaborators Publish Peer-Reviewed Article Highlighting Current Limitations and Future Innovations for Barrett's Esophagus-Related Cancer

ACCESS Newswire September 9, 2021
View More News ››

Opinion & Analysis ()

No current opinion is available.
View More Opinion ››

Bullboard Posts ()

Be the first to post on this bullboard.

Playboy Inc.

Playboy Inc.

Playboy, Inc. operates as a pleasure and leisure company in the United States, Australia, China, the United Kingdom, and ...
View More »

Podcasts